Epidemiology of treatment resistant depression among major depressive disorder patients in israel

HIGHLIGHTS

• who: Sarah Sharman Moser from the Psychiatric Hospitalizations have published the article: Epidemiology of treatment resistant depression among major depressive disorder patients in Israel, in the Journal: (JOURNAL)
• what: The study shows that prevalence of MDD in Israel is low compared to other countries, however once diagnosed, patients' are likely to receive drug treatment. The study shows that median time on L1 treatment was 3.6 months and 18% had a single medication purchase only.
• how: The authors identified MHS members aged 18 to 65 years with the start of any MDD episode . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.